Efficacy of covered stent placement for central venous occlusive disease in hemodialysis patients

Anaya‐Ayala, Javier E.; Smolock, Christopher J.; Colvard, Benjamin; Naoum, Joseph J.; Bismuth, Jean; Lumsden, Alan B.; Davies, Mark G.; Peden, Eric K.

doi:10.1016/j.jvs.2011.03.260

Cited by 103 publications

(77 citation statements)

References 21 publications

(31 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Furthermore, it is already evident that all stents can provoke intimal hyperplasia, leading to recurrent stenosis and multiple interventions to maintain patency. 22 However, in common with balloon angioplasties, stents also demonstrate a wide range of variability in relation to patency after treatment of COVD. Patency can vary from 72 to 100% at 3 months, through 55 to 100% at 6 months to 56 to 97% at 12 months.…”

Section: Discussionmentioning

confidence: 99%

Endovascular treatment of occlusive central venous disease: one center's experience

Silvestre¹,

Trevisan²,

Sardinha³

et al. 2014

J. vasc. bras.

View full text Add to dashboard Cite

Introduction: The majority of cases of stenosis or occlusion of central veins are the result of central catheters, arteriovenous fistulas, neoplasms or traumas and these conditions can cause severe cases of venous hypertension or reduce the flow through fistulas. The objective of this study is to analyze the results of central venous angioplasties conducted at our hospital. Methodology: We conducted a retrospective and descriptive study to analyze the results of central venous angioplasties conducted from 2010 to 2012 at a university hospital run by the Universidade Estadual de Londrina, Brazil. We calculated primary and secondary success rates and analyzed whether or not stents were used and complications occurred during a 6-month follow-up period. Results: A total of 25 central venous angioplasties were conducted. Twenty-four (96%) of these were because of catheter-related intimal hyperplasia and one was to treat the effects of compression by a tumor. Fifteen (60%) angioplasties were to correct stenosis and ten (40%) were because of occlusions, with a one-hundred percent success rate for all stenosis-related procedures. However, none of the cases of occlusion could be treated endovascularly. Patency during the 6-months follow-up period was 80% after reinterventions. Conclusions: Despite good results observed after primary interventions for stenoses, it must be accepted that all current treatment options for chronic occlusive venous disease will, sooner or later, lead to restenosis or occlusion. Venous occlusions constitute a challenge demanding the development of new techniques and new materials. Prevention is paramount, through avoidance of central catheterization and early creation of arteriovenous fistulas.

show abstract

Section: Discussionmentioning

confidence: 99%

Endovascular treatment of occlusive central venous disease: one center's experience

Silvestre¹,

Trevisan²,

Sardinha³

et al. 2014

J. vasc. bras.

View full text Add to dashboard Cite

show abstract

“…However, surgical approaches require general anesthesia and exhibit a high rate of surgical morbidity when used in cases with end-stage renal disease. As an alternative to surgical treatments, endovascular interventions have been performed for over 10 years and have obtained appreciable success rates and benefits, although repeated interventions have still been required in certain cases [6–8]. …”

Section: Introductionmentioning

confidence: 99%

The feasibility and safety of a through-and-through wire technique for central venous occlusion in dialysis patients

Huang

Chen

Tan

et al. 2016

BMC Cardiovasc Disord

View full text Add to dashboard Cite

BackgroundTo retrospectively compare the operation time, success rate and efficacy between unidirectional and bidirectional procedures in the treatment of central venous occlusion diseases (CVOD), assess the advantages of the bidirectional approach, and determine the characteristics of CVOD appropriate for the bidirectional approach treatment.MethodsA total of 49 patients who underwent endovascular interventions with all relevant data between January 2011 and December 2015 at the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China, were included in this retrospective study, and were categorized into two groups: the 19 patients in group 1 had undergone percutaneous transluminal venoplasty (PTV) via a conventional technique (unidirectional procedure from the vein distal or proximal to the obstructive lesion), and the 30 in group 2 had undergone flossing wire technique (bidirectional procedure from femoral vein and the vein distal to obstructive lesion and using a flossing wire technique). The technical success rate, the fluoroscopy time in the procedure, perioperative complications, and patency were evaluated retrospectively.ResultsCompared with group 1, group 2 had a higher initial technical success rate (83.33% vs. 47.36%, p = 0.012) but a shorter fluoroscopy time (82.6 ± 26.1 vs. 116.1 ± 42.1, p = 0.048). Receiver operating characteristic (ROC) analysis indicated that a lesion with a length of 6.5 cm was the best predictor of technique success (p = 0.02) in group 1, but no cut-off value was identified for group 2. There were no significant differences in perioperative complications between these two groups. The complication rates were 31.58% (6/19) in group 1 and 6.67% (2/30) in group 2, (p = 0.043), respectively. No significant difference was observed between these two groups with respect to the stent patency rate.ConclusionCompared with the conventional technique, the flossing wire technique has a higher success rate, shorter fluoroscopy time, fewer complications and similar patency rate. It is a feasible treatment for CVOD, especially for long obstructive lesions.

show abstract

“…We consider that this calibre would be sufficient to recanalise successfully the vessel and to displace and compress the filter. Additionally in the case of central venous occlusion covered stents have demonstrated better technical results and longer patency rates than bare metal stents,13 and reports have shown the utility of these devices for haemorrhage control in the case of vein rupture 14 15…”

Section: Discussionmentioning

confidence: 99%

Endovascular recanalisation of a chronic occlusion of the retrohepatic IVC associated to a filter in a patient with antiphospholipid syndrome

et al. 2017

View full text Add to dashboard Cite

Inferior vena cava (IVC) filters are useful adjuncts to prevent venous thromboembolism to the pulmonary circulation in the setting of contraindication for anticoagulation. Despite their proven decreased rate of pulmonary embolism, IVC filters are not without complications. We herein present the case of a 22-year-old man with a history of antiphospholipid antibody syndrome who was sent to our institution for evaluation with Budd-Chiari and post-thrombotic syndromes associated to a chronic retrohepatic complete IVC occlusion secondary to an IVC filter placed 5 years earlier. Via common femoral, transjugular and transhepatic accesses, we performed a successful endovascular recanalisation and reconstruction of the IVC with a 16 mm×60 mm covered stent; the hepatic outflow was restored with an 8×20 mm Palmaz stent. At 12-month follow-up, his symptoms have resolved, and his liver tests are within normal limits. He remains on systemic anticoagulation.

show abstract

Efficacy of covered stent placement for central venous occlusive disease in hemodialysis patients

Cited by 103 publications

References 21 publications

Endovascular treatment of occlusive central venous disease: one center's experience

Endovascular treatment of occlusive central venous disease: one center's experience

The feasibility and safety of a through-and-through wire technique for central venous occlusion in dialysis patients

Endovascular recanalisation of a chronic occlusion of the retrohepatic IVC associated to a filter in a patient with antiphospholipid syndrome

Contact Info

Product

Resources

About